regorafenib,xl092,atezolizumab
roche,vjoncology,bayer,exelixis
['rectal', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'colorectal', 'atezo', 'xl092', 'regorafenib', 'crcsm', 'stellar-303', 'vj oncology', 'vjoncology']
we spoke with j. randolph hecht of who updated us on stellar-303, a phase 3 study of xl092 in combination with atezolizumab vs regorafenib in patients with previously treated metastatic #colorectalcancer #asco23 #oncology #crcsm 
The Video Journal of Oncology is dedicated to providing up-to-date information & international expertise on #Oncology #BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm